Holly Stafford
About Holly Stafford
Holly Stafford is a Senior Recruiter at Kite Pharma, specializing in recruiting for cancer immunotherapy and cell therapy roles. With over a decade of experience in the biotechnology and pharmaceutical industries, she has a proven track record in identifying top talent for engineered T cell therapy positions.
Work at NXTThing RPO
Holly Stafford has been employed at NXTThing RPO as a Senior Recruiter since 2019. In this role, she focuses on identifying and recruiting talent for various positions within the organization. Her experience in recruitment spans several years, contributing to her effectiveness in sourcing candidates that align with organizational needs.
Previous Experience at ADP
Before joining NXTThing RPO, Holly Stafford worked at ADP RPO, LLC as a Senior Recruiting Specialist from 2009 to 2019. During her decade-long tenure in Wayne, PA, she developed a strong foundation in recruitment strategies and candidate sourcing, which she has applied in her subsequent roles.
Current Role at Kite Pharma
Since 2021, Holly Stafford has served as a Senior Recruiter at Kite, A Gilead Company, located in Frederick, Maryland. In this position, she specializes in recruiting for cancer immunotherapy and cell therapy roles. Her work directly supports Kite's mission to advance innovative cell therapy projects aimed at curing cancer.
Education and Expertise
Holly Stafford earned a Bachelor of Science degree in Business Administration from Elizabethtown College. Her educational background complements her extensive experience in recruitment, particularly in the biotechnology and pharmaceutical sectors. She has developed expertise in sourcing strategies tailored to these industries.
Specialization in Biotechnology Recruitment
Holly Stafford specializes in recruiting for roles related to cancer immunotherapy and engineered T cell therapy. She has a strong track record of identifying and attracting top talent in these specialized fields, contributing to the advancement of innovative therapies in the biotechnology sector.